Risperidone long-acting injectable (Risperdal Consta)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Risperidone long-acting injectable (Risperdal Consta), covering 2010-08-10 to 2013-07-25. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders [Phase 4]